Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Ehlers

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Endocrine|April 27, 2001
Recombinant human GHRH(1-44)NH2: clinical utility and therapeutic development programM R Ehlers
Microbes and Infection|April 12, 2000
CR3: a general purpose adhesion-recognition receptor essential for innate immunityM R Ehlers
Trends in Microbiology|September 25, 1998
Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key?M R Ehlers, M Daffé
Biochemistry|July 23, 1991
Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymesM R Ehlers, J F Riordan
Neurobiology of Learning and Memory|September 13, 2017
Acute psychophysiological stress impairs human associative learningM R Ehlers, R M Todd
Biochemistry|July 26, 1988
Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pHM R Ehlers, R E Kirsch
Biochemical and Biophysical Research Communications|April 15, 1992
The functional role of tyrosine-200 in human testis angiotensin-converting enzymeY N Chen, M R Ehlers, J F Riordan
Biochimica Et Biophysica Acta|September 4, 1986
Rapid affinity chromatographic purification of human lung and kidney angiotensin-converting enzyme with the novel N-carboxyalkyl dipeptide inhibitor N-[1(S)-carboxy-5-aminopentyl]glycylglycineM R Ehlers, D L Maeder, R E Kirsch
Biochemical and Biophysical Research Communications|February 28, 1992
The unique N-terminal sequence of testis angiotensin-converting enzyme is heavily O-glycosylated and unessential for activity or stabilityM R Ehlers, Y N Chen, J F Riordan
Diabetes, Obesity & Metabolism|November 21, 2013
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitusS S Torekov, J J Holst, M R Ehlers
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Endocrine|April 27, 2001
Recombinant human GHRH(1-44)NH2: clinical utility and therapeutic development programM R Ehlers
Microbes and Infection|April 12, 2000
CR3: a general purpose adhesion-recognition receptor essential for innate immunityM R Ehlers
Trends in Microbiology|September 25, 1998
Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key?M R Ehlers, M Daffé
Biochemistry|July 23, 1991
Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymesM R Ehlers, J F Riordan
Neurobiology of Learning and Memory|September 13, 2017
Acute psychophysiological stress impairs human associative learningM R Ehlers, R M Todd
Biochemistry|July 26, 1988
Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pHM R Ehlers, R E Kirsch
Biochemical and Biophysical Research Communications|April 15, 1992
The functional role of tyrosine-200 in human testis angiotensin-converting enzymeY N Chen, M R Ehlers, J F Riordan
Biochimica Et Biophysica Acta|September 4, 1986
Rapid affinity chromatographic purification of human lung and kidney angiotensin-converting enzyme with the novel N-carboxyalkyl dipeptide inhibitor N-[1(S)-carboxy-5-aminopentyl]glycylglycineM R Ehlers, D L Maeder, R E Kirsch
Biochemical and Biophysical Research Communications|February 28, 1992
The unique N-terminal sequence of testis angiotensin-converting enzyme is heavily O-glycosylated and unessential for activity or stabilityM R Ehlers, Y N Chen, J F Riordan
Diabetes, Obesity & Metabolism|November 21, 2013
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitusS S Torekov, J J Holst, M R Ehlers
Pageof 4